The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Eisai Europe; HRA Pharma; Lilly; PharmaMar; Roche
Research Funding - Novartis (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Roche
Comparative patient-reported tolerability (PRT): A multiplicity-controlled analysis of LIBRETTO-531, a randomized controlled trial (RCT) in medullary thyroid cancer (MTC).
 
Marcia S. Brose
Honoraria - Bayer; Eisai; Lilly
Consulting or Advisory Role - AADi; Bayer; Eisai; Exelixis; Lilly; Loxo
Research Funding - Lilly (Inst); Loxo (Inst)
 
Bruce Robinson
No Relationships to Disclose
 
Lori J. Wirth
Consulting or Advisory Role - Bayer; Coherus Biosciences; Curie Therapeutics; Eisai; Exelixis; Lilly; Merck; METIS Precision Medicine; Morphic Therapeutic; Tome Biosciences
Research Funding - Checkmate Pharmaceuticals (Inst); Eisai (Inst); Lilly (Inst); Novartis (Inst)
Expert Testimony - Eisai
Other Relationship - PDS Biotechnology
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Gilead Sciences (Inst); Ipsen (Inst); Ipsen (Inst); ITM Solucin (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Eisai; Gilead Sciences; Ipsen; Pfizer
 
Jonathan Wadsley
Travel, Accommodations, Expenses - Novartis, Bayer, Roche
 
Eric Jeffrey Sherman
Consulting or Advisory Role - AffyImmune Therapeutics; Blueprint Medicines; Eisai; Exelixis; Lilly; UpToDate
Research Funding - Fore Biotherapeutics (Inst); HUTCHMED (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst)
 
Makoto Tahara
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Genmab; GlaxoSmithKline; Janssen; Lilly; Merck KGaA; MSD; Nanobiotix; Ono Pharmaceutical; Pfizer; Rakuten Medical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Rakuten Medical (Inst)
 
Ana Hoff
Leadership - Oncologia D'OR - President
Stock and Other Ownership Interests - OncoStar
Honoraria - United, Bayer
Consulting or Advisory Role - Eli Lilly ,United
Research Funding - Eli Lilly, Exelixis, Novartis
 
Mimi I-Nan Hu
Employment - crispr therapeutics (I)
Research Funding - Lilly
Other Relationship - Lilly
 
Ming Gao
No Relationships to Disclose
 
Fernanda Vaisman
Consulting or Advisory Role - Ipsen, Eli Lilly, Merck
Speakers' Bureau - Knight, Lilly, Merck, Sanofi-Genzyme
Research Funding - Exelixis, Novartis, Eli Lilly
Travel, Accommodations, Expenses - Sanofi- Genzyme, Knight, Merck, Eli Lilly
 
Collin Churchill
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Boris K. Lin
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
 
Patricia H Maeda
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Adrienne M. Gilligan
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Yan Lin
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
 
Nalin Payakachat
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Julien Hadoux
No Relationships to Disclose
 
Rossella Elisei
Consulting or Advisory Role - Bayer; EISAI; Ipsen; Lilly